Moderna is set for the global launch of Covid-19 vaccine

Moderna is aiming to produce 20 million doses of its experimental vaccine by the end of 2020.

Moderna, American Biotechnology, Coronavirus Vaccine, mRNA1273, Global Launch, Top English News, True Scoop- True Scoop

American biotechnology company Moderna announced that it was preparing for the global launch of its Covid-19 vaccine candidate.

"We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around the world," Xinhua news agency quoted Moderna CEO Stephane Bancel as saying in a statement on Thursday.

In addition to the Phase 3 study of the Covid-19 vaccine mRNA-1273, which is fully enrolled, Moderna now has four programs in Phase 2 studies, according to Bancel.

"Moderna is committed to the highest data quality standards and rigorous scientific research as we continue to work with regulators to advance mRNA-1273," he said.

On October 22, the Phase 3 study of mRNA-1273 completed enrollment of 30,000 participants with approximately 37 per cent of participants from diverse communities.

Also Read: People with Cognitive disorders may suffer from the dangers of developing severe Covid-19, says Study

The Phase 1 interim analysis of the vaccine, published in The New England Journal of Medicine on July 14, showed that mRNA-1273 was generally well-tolerated across all age groups and induced rapid and strong immune responses against SARS-CoV-2.

With agency inputs


Trending